MAGE-Like 2 anticorps (C-Term)
Aperçu rapide pour MAGE-Like 2 anticorps (C-Term) (ABIN929381)
Antigène
Voir toutes MAGE-Like 2 (MAGEL2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Purified
-
Immunogène
- MAGEL2 antibody was raised in rabbit using the C terminal of MAGEL2 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
MAGEL2 Blocking Peptide, (ABIN5614639), is also available for use as a blocking control in assays to test for specificity of this MAGEL2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- MAGE-Like 2 (MAGEL2)
-
Autre désignation
- MAGEL2
-
Sujet
- Prader-Willi syndrome (PWS) is caused by the loss of expression of imprinted genes in chromosome 15q11-q13 region. Affected individuals exhibit neonatal hypotonia, developmental delay, and childhood-onset obesity. Necdin (NDN), a gene involved in the terminal differentiation of neurons, localizes to this region of the genome and has been implicated as one of the genes responsible for the etiology of PWS. This gene is structurally similar to NDN, is also localized to the PWS chromosomal region, and is paternally imprinted, suggesting a possible role for it in PWS. Synonyms: Polyclonal MAGEL2 antibody, Anti-MAGEL2 antibody, MAGE-like 2 antibody, NDNL1 antibody, nM15 antibody.
Antigène
-